For years, the network fabric inside data centers were built for relatively predictable traffic flows. Testing this ...
We talked to experts in obesity, tobacco, artificial intelligence, HIV, TB and the NHI to find out what we can expect — and ...
Clinuvel Pharmaceuticals (ASX:CUV) has begun dosing patients in a preclinical study of its controlled-release liquid injectable peptide platform, VLRX-L. This marks the first formal test of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results